Sumera Qasim, Alamgeer, Saima Kalsoom, Hafiz Muhammad Irfan, Sajid Bashir, Zahid Rasul Niazi
Atorvastatin, an HMG-CoA reductase inhibitor, has been employed in the current study with animal models
Atorvastatin
in-vitro
in-vivo
arthritis
molecular docking.